Literature DB >> 20956071

2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.

J M Haro1, C Reed, A Gonzalez-Pinto, D Novick, J Bertsch, E Vieta.   

Abstract

EMBLEM is a 2-year, prospective, observational study that enrolled patients initiating/changing oral treatment for an acute manic/mixed episode. This paper analysed remission and functional recovery in 1656 patients who entered the 2-year long-term phase. Cox models identified variables significantly associated with achieving remission and functional recovery at 2years. Of these patients, 64% achieved remission and 34% achieved functional recovery. Patients with a higher CGI-BP overall score at baseline, who had depressive episodes in the year before inclusion and who had poor social functioning (work or social impairment, not living independently or without a spouse/partner) were less likely to achieve remission or recovery. Prescription of typical antipsychotics and prescription of antidepressants at the first visit of the long-term treatment phase (12weeks) were independent predictors of lower remission and recovery rates. In conclusion, functional recovery occurred in approximately half of those who achieved remission. Impairment of work and social functioning was consistently associated with lower remission and recovery rates.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20956071     DOI: 10.1016/j.euroneuro.2010.08.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  13 in total

1.  The diagnosis and treatment of bipolar disorder: decision-making in primary care.

Authors:  Larry Culpepper
Journal:  Prim Care Companion CNS Disord       Date:  2014-06-19

2.  Social Aspect of Functioning Deteriorates More Than Individual Aspect in Patients with Remitted Bipolar Disorder.

Authors:  Arzu Tiğli Filizer; Cem Cerit; Başak Tüzün; Ahmet Tamer Aker
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

Review 3.  Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics?

Authors:  Iria Grande; Eduard Vieta
Journal:  CNS Drugs       Date:  2015-03       Impact factor: 5.749

4.  Predictors of Treatment Resistance Across Different Clinical Subtypes of Depression: Comparison of Unipolar vs. Bipolar Cases.

Authors:  Michele Fornaro; Andrea Fusco; Stefano Novello; Pierluigi Mosca; Annalisa Anastasia; Antonella De Blasio; Felice Iasevoli; Andrea de Bartolomeis
Journal:  Front Psychiatry       Date:  2020-05-15       Impact factor: 4.157

5.  Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders.

Authors:  Boris Birmaher; Mary Kay Gill; David A Axelson; Benjamin I Goldstein; Tina R Goldstein; Haifeng Yu; Fangzi Liao; Satish Iyengar; Rasim S Diler; Michael Strober; Heather Hower; Shirley Yen; Jeffrey Hunt; John A Merranko; Neal D Ryan; Martin B Keller
Journal:  Am J Psychiatry       Date:  2014-09       Impact factor: 18.112

6.  The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder.

Authors:  C M Bonnín; C Torrent; J M Goikolea; M Reinares; B Solé; M Valentí; J Sánchez-Moreno; D Hidalgo; R Tabarés-Seisdedos; A Martínez-Arán; E Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-08-03       Impact factor: 5.270

7.  Self-Management Strategies in Recovery From Mood and Anxiety Disorders.

Authors:  Benjamin Villaggi; Hélène Provencher; Simon Coulombe; Sophie Meunier; Stephanie Radziszewski; Catherine Hudon; Pasquale Roberge; Martin D Provencher; Janie Houle
Journal:  Glob Qual Nurs Res       Date:  2015-09-21

8.  How assess drugs in the treatment of acute bipolar mania?

Authors:  Michel Bourin; Florence Thibaut
Journal:  Front Pharmacol       Date:  2013-01-29       Impact factor: 5.810

9.  A Network Approach to Bipolar Symptomatology in Patients with Different Course Types.

Authors:  M A Koenders; R de Kleijn; E J Giltay; B M Elzinga; P Spinhoven; A T Spijker
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

10.  Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).

Authors:  Takashi Tsuboi; Takefumi Suzuki; Takaharu Azekawa; Naoto Adachi; Hitoshi Ueda; Kouji Edagawa; Eiichi Katsumoto; Yukihisa Kubota; Eiichiro Goto; Seiji Hongo; Yoichiro Watanabe; Masaki Kato; Norio Yasui-Furukori; Reiji Yoshimura; Atsuo Nakagawa; Toshiaki Kikuchi; Koichiro Watanabe
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-31       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.